LANOLIN AND PETROLATUM

LANOLIN AND PETROLATUM was reported 264 times

LANOLIN AND PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCREASED ANTEROPOSTERIOR CHEST DIAMETER 1 0.1250
1 MONONUCLEAR CELL COUNT INCREASED 1 0.0909
2 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING BY CHILD 1 0.0476
3 PRURITUS ANI 1 0.0169
4 CITROBACTER TEST POSITIVE 1 0.0152
5 REFLUX NEPHROPATHY 1 0.0152
6 RECTAL CANCER RECURRENT 1 0.0118
7 OLIGODENDROGLIOMA 1 0.0083
8 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
9 HYPERBARIC OXYGEN THERAPY 1 0.0060
10 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
11 PYELONEPHRITIS CHRONIC 1 0.0053
12 CD8 LYMPHOCYTES DECREASED 1 0.0050
13 PORTAL FIBROSIS 1 0.0047
14 PROTEUS TEST POSITIVE 1 0.0045
15 BIOPSY LIVER ABNORMAL 1 0.0033
16 GENITAL PRURITUS FEMALE 1 0.0031
17 DISTAL INTESTINAL OBSTRUCTION SYNDROME 1 0.0030
18 HYPOCHROMIC ANAEMIA 3 0.0030
19 CUBITAL TUNNEL SYNDROME 1 0.0029
20 FAT EMBOLISM 1 0.0028
21 SKIN TURGOR DECREASED 1 0.0026
22 HEMIPARAESTHESIA 1 0.0026
23 EXPOSURE VIA EYE CONTACT 1 0.0024
24 COLONOSCOPY ABNORMAL 1 0.0023
25 BONE DEBRIDEMENT 1 0.0021
26 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
27 LUNG INFECTION PSEUDOMONAL 1 0.0018
28 RECTOCELE 1 0.0017
29 VESTIBULAR DISORDER 2 0.0016
30 BLOOD CORTISOL DECREASED 1 0.0016
31 ABDOMINAL WALL ABSCESS 1 0.0015
32 MACULAR FIBROSIS 1 0.0015
33 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
34 FLUID IMBALANCE 1 0.0014
35 SPUTUM INCREASED 3 0.0014
36 NODAL RHYTHM 2 0.0014
37 CHOLANGITIS ACUTE 1 0.0013
38 TRACHEITIS 1 0.0013
39 ADRENAL SUPPRESSION 1 0.0012
40 OVARIAN CANCER METASTATIC 1 0.0012
41 CRANIOFACIAL FRACTURE 1 0.0012
42 SPINAL CORD NEOPLASM 1 0.0011
43 ANAEMIA OF CHRONIC DISEASE 1 0.0011
44 ACTINOMYCOSIS 1 0.0010
45 EYELID PAIN 2 0.0010
46 GALLBLADDER ENLARGEMENT 1 0.0009
47 INFUSION SITE MASS 1 0.0009
48 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
49 FACIAL SPASM 1 0.0009
50 LIGAMENT INJURY 1 0.0009
51 PRIAPISM 3 0.0009
52 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
53 APPLICATION SITE EROSION 1 0.0008
54 ACROCHORDON 1 0.0008
55 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
56 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
57 RHONCHI 1 0.0007
58 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
59 PRECANCEROUS CELLS PRESENT 1 0.0007
60 SINUS ARREST 1 0.0006
61 OPTIC NERVE DISORDER 1 0.0006
62 EROSIVE OESOPHAGITIS 1 0.0006
63 BILIARY DYSKINESIA 1 0.0006
64 TREATMENT DELAYED 1 0.0006
65 OTORRHOEA 1 0.0006
66 INFUSION SITE DISCHARGE 1 0.0006
67 KYPHOSIS 1 0.0006
68 PANCREATIC FAILURE 1 0.0006
69 HISTOPLASMOSIS 1 0.0006
70 FIBRIN D DIMER INCREASED 2 0.0006
71 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
72 PARAPARESIS 1 0.0006
73 ESSENTIAL HYPERTENSION 1 0.0005
74 SINUS NODE DYSFUNCTION 1 0.0005
75 BLOOD IRON INCREASED 1 0.0005
76 PERONEAL NERVE PALSY 3 0.0005
77 HYPERCOAGULATION 1 0.0005
78 RENAL HAEMORRHAGE 1 0.0005
79 CHOLANGITIS SCLEROSING 1 0.0005
80 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
81 CD4 LYMPHOCYTES DECREASED 1 0.0005
82 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
83 PULMONARY FUNCTION TEST DECREASED 2 0.0005
84 PRODUCT LOT NUMBER ISSUE 1 0.0005
85 GASTRIC POLYPS 1 0.0004
86 VASCULAR DEVICE INFECTION 2 0.0004
87 ABNORMAL LOSS OF WEIGHT 3 0.0004
88 READING DISORDER 1 0.0004
89 NEUROLOGICAL DECOMPENSATION 1 0.0004
90 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
91 INGROWING NAIL 1 0.0004
92 SINUS OPERATION 1 0.0004
93 FOOT OPERATION 2 0.0004
94 EYELID IRRITATION 1 0.0004
95 VASODILATATION 1 0.0004
96 CHEMICAL BURN OF SKIN 1 0.0004
97 ENDODONTIC PROCEDURE 1 0.0004
98 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
99 SERUM FERRITIN INCREASED 2 0.0004
100 BLOOD POTASSIUM ABNORMAL 1 0.0004
101 ULCERATIVE KERATITIS 1 0.0004
102 CREPITATIONS 1 0.0003
103 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
104 RECTAL CANCER 1 0.0003
105 PORTAL HYPERTENSION 1 0.0003
106 INFUSION SITE PRURITUS 1 0.0003
107 FACET JOINT SYNDROME 1 0.0003
108 NEOPLASM RECURRENCE 1 0.0003
109 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
110 HEPATIC FIBROSIS 1 0.0003
111 DIFFICULTY IN WALKING 1 0.0003
112 THROMBOPHLEBITIS 1 0.0003
113 APPENDICECTOMY 1 0.0003
114 NEUTROPENIC SEPSIS 2 0.0003
115 MONOCYTE COUNT INCREASED 1 0.0003
116 DENTAL CARIES 3 0.0003
117 WOUND HAEMORRHAGE 1 0.0003
118 HYDRONEPHROSIS 2 0.0003
119 PARANASAL SINUS HYPERSECRETION 1 0.0003
120 THYROID MASS 1 0.0003
121 WOUND SECRETION 1 0.0003
122 PRODUCT USE COMPLAINT 4 0.0003
123 RENAL CYST 2 0.0003
124 SKIN PAPILLOMA 1 0.0002
125 STENT PLACEMENT 2 0.0002
126 PERIPHERAL VENOUS DISEASE 1 0.0002
127 PERIPHERAL ISCHAEMIA 1 0.0002
128 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
129 SECOND PRIMARY MALIGNANCY 2 0.0002
130 ONYCHOMADESIS 1 0.0002
131 LIP OEDEMA 1 0.0002
132 PRODUCT CONTAINER ISSUE 2 0.0002
133 MONOPLEGIA 1 0.0002
134 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
135 MELANOCYTIC NAEVUS 1 0.0002
136 ONYCHOMYCOSIS 1 0.0002
137 ABDOMINAL ABSCESS 1 0.0002
138 RHEUMATIC FEVER 1 0.0002
139 EAR DISORDER 1 0.0002
140 ISCHAEMIA 1 0.0002
141 ROSACEA 1 0.0002
142 HYPOVOLAEMIC SHOCK 1 0.0002
143 FINGER DEFORMITY 1 0.0002
144 APPLICATION SITE BURN 1 0.0002
145 STAPHYLOCOCCAL SEPSIS 1 0.0002
146 BLADDER DISORDER 2 0.0002
147 KLEBSIELLA INFECTION 1 0.0002
148 TOE AMPUTATION 1 0.0002
149 CACHEXIA 1 0.0002
150 SKIN NECROSIS 1 0.0002
151 MALABSORPTION 1 0.0002
152 PRODUCT ODOUR ABNORMAL 2 0.0002
153 FOOD POISONING 1 0.0002
154 GINGIVITIS 1 0.0002
155 STRESS FRACTURE 1 0.0002
156 NORMAL NEWBORN 1 0.0002
157 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
158 MACULAR OEDEMA 1 0.0002
159 PRODUCT LEAKAGE 1 0.0002
160 CARDIAC VALVE DISEASE 1 0.0002
161 EXERCISE TOLERANCE DECREASED 1 0.0002
162 RALES 1 0.0002
163 PRODUCT LABEL CONFUSION 1 0.0002
164 DECREASED INTEREST 1 0.0002
165 DRUG ABUSER 1 0.0002
166 INFUSION SITE SWELLING 1 0.0002
167 BLEPHAROSPASM 1 0.0002
168 PHOTOPSIA 1 0.0002
169 SCREAMING 1 0.0002
170 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
171 POOR QUALITY DRUG ADMINISTERED 1 0.0002
172 BREAST CANCER STAGE III 1 0.0002
173 APPLICATION SITE VESICLES 1 0.0002
174 PLATELET COUNT INCREASED 2 0.0002
175 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
176 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
177 POST-TRAUMATIC STRESS DISORDER 1 0.0001
178 BRONCHIECTASIS 1 0.0001
179 PRODUCT LABEL ISSUE 1 0.0001
180 CORONARY ARTERY OCCLUSION 2 0.0001
181 LYMPHOEDEMA 1 0.0001
182 LARGE INTESTINE POLYP 1 0.0001
183 AUTOIMMUNE HEPATITIS 1 0.0001
184 APHONIA 2 0.0001
185 SEASONAL ALLERGY 2 0.0001
186 DIVERTICULUM 1 0.0001
187 RED BLOOD CELL COUNT DECREASED 4 0.0001
188 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
189 VISUAL FIELD DEFECT 1 0.0001
190 APPLICATION SITE PAIN 3 0.0001
191 ARTHROPOD BITE 1 0.0001
192 DUODENAL ULCER PERFORATION 1 0.0001
193 MUSCULOSKELETAL PAIN 7 0.0001
194 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
195 RENAL FAILURE CHRONIC 1 0.0001
196 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
197 HAEMOLYSIS 1 0.0001
198 MUSCULOSKELETAL CHEST PAIN 2 0.0001
199 ACUTE MYELOID LEUKAEMIA 2 0.0001
200 AFFECTIVE DISORDER 1 0.0001
201 DRUG SCREEN POSITIVE 1 0.0001
202 RESPIRATORY TRACT CONGESTION 2 0.0001
203 OBESITY 2 0.0001
204 SENSORY LOSS 1 0.0001
205 DECUBITUS ULCER 1 0.0001
206 ESCHERICHIA INFECTION 1 0.0001
207 MENSTRUAL DISORDER 1 0.0001
208 MUSCLE INJURY 1 0.0001
209 EXPIRED PRODUCT ADMINISTERED 4 0.0001
210 LIVE BIRTH 1 0.0001
211 BLOOD MAGNESIUM DECREASED 1 0.0001
212 MUSCLE STRAIN 1 0.0001
213 PYELONEPHRITIS 1 0.0001
214 NAIL DISORDER 1 0.0001
215 GRIP STRENGTH DECREASED 1 0.0001
216 COLD SWEAT 2 0.0001
217 HAEMOLYTIC ANAEMIA 1 0.0001
218 HAEMARTHROSIS 1 0.0001
219 ANAL INCONTINENCE 1 0.0001
220 OROPHARYNGEAL DISCOMFORT 1 0.0001
221 LIP DRY 1 0.0001
222 BONE DISORDER 2 0.0001
223 EXOSTOSIS 1 0.0001
224 RETINAL DETACHMENT 1 0.0001
225 LACERATION 1 0.0001
226 FOOT FRACTURE 2 0.0001
227 SPUTUM DISCOLOURED 1 0.0001
228 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
229 POST PROCEDURAL COMPLICATION 2 0.0001
230 HYPERCHOLESTEROLAEMIA 1 0.0001
231 VITAMIN D DEFICIENCY 1 0.0001
232 SKIN FISSURES 2 0.0001
233 COELIAC DISEASE 1 0.0001
234 HEPATOMEGALY 1 0.0001
235 VITREOUS FLOATERS 1 0.0001
236 HOSPICE CARE 1 0.0001
237 LIGAMENT SPRAIN 1 0.0001
238 HYPOTONIA 1 0.0001
239 OVARIAN CYST 1 0.0001
240 BLOOD POTASSIUM DECREASED 3 0.0001
241 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
242 EYELID PTOSIS 1 0.0001
243 TOOTH ABSCESS 1 0.0001
244 SLUGGISHNESS 1 0.0001
245 NEUTROPHIL COUNT INCREASED 1 0.0001
246 HELICOBACTER INFECTION 1 0.0001
247 TEMPERATURE INTOLERANCE 1 0.0001
248 HYPERBILIRUBINAEMIA 1 0.0001
249 VENTRICULAR EXTRASYSTOLES 1 0.0001
250 EYE DISCHARGE 1 0.0001
251 INTENTIONAL DRUG MISUSE 2 0.0001
252 FOLLICULITIS 1 0.0001
253 INCONTINENCE 1 0.0001
254 JOINT DISLOCATION 1 0.0001
255 JOINT INJURY 2 0.0001
256 NIGHT SWEATS 3 0.0001
257 FAECES DISCOLOURED 2 0.0001
258 BACK INJURY 1 0.0001
259 WOUND INFECTION 1 0.0001
260 GASTROINTESTINAL PAIN 1 0.0001
261 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
262 OCULAR DISCOMFORT 1 0.0001
263 EYE PAIN 5 0.0001
264 STATUS EPILEPTICUS 1 0.0001
265 DERMATITIS CONTACT 1 0.0001
266 SPLENOMEGALY 1 0.0001
267 SPINAL PAIN 1 0.0001
268 WHEEZING 5 0.0001
269 HYPERLIPIDAEMIA 1 0.0001
270 HEPATITIS C 1 0.0001
271 BURSITIS 1 0.0001
272 NO THERAPEUTIC RESPONSE 1 0.0001
273 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
274 ILEUS 1 0.0001
275 APPLICATION SITE IRRITATION 1 0.0001
276 TOOTH EXTRACTION 1 0.0001
277 PEMPHIGUS 1 0.0001
278 SECRETION DISCHARGE 1 0.0001
279 CELLULITIS 4 0.0001
280 COLITIS 3 0.0001
281 ANOREXIA 1 0.0001
282 SPEECH DISORDER 4 0.0001
283 HAND DEFORMITY 1 0.0001
284 INCORRECT PRODUCT STORAGE 1 0.0001
285 TOOTH INFECTION 1 0.0001
286 ADVERSE REACTION 1 0.0001
287 JOINT RANGE OF MOTION DECREASED 1 0.0001
288 SINUS CONGESTION 1 0.0001
289 ORAL DISCOMFORT 1 0.0001
290 BLISTER 4 0.0001
291 BLOOD TEST ABNORMAL 1 0.0001
292 DEVICE OCCLUSION 1 0.0001
293 HEPATOCELLULAR INJURY 1 0.0001
294 MUSCULAR WEAKNESS 8 0.0001
295 SUBDURAL HAEMATOMA 1 0.0001
296 HYPERSOMNIA 2 0.0001
297 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
298 HAEMOGLOBIN DECREASED 7 0.0001
299 SKIN HAEMORRHAGE 1 0.0001
300 HAEMORRHAGE INTRACRANIAL 1 0.0001
301 RESPIRATORY DISORDER 2 0.0001
302 HYPOAESTHESIA ORAL 1 0.0001
303 INSURANCE ISSUE 1 0.0001
304 FEELING HOT 4 0.0001
305 DRUG-INDUCED LIVER INJURY 2 0.0001
306 ULCER 1 0.0001
307 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
308 SENSORY DISTURBANCE 1 0.0001
309 MUSCLE TIGHTNESS 1 0.0001
310 INFUSION RELATED REACTION 4 0.0001
311 PERICARDITIS 1 0.0001
312 DELIRIUM 2 0.0001
313 SYRINGE ISSUE 1 0.0001
314 BRADYCARDIA 3 0.0001
315 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
316 GALLBLADDER DISORDER 1 0.0001
317 GOUT 1 0.0001
318 SYNOVITIS 1 0.0001
319 GASTROENTERITIS VIRAL 1 0.0001
320 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
321 TOOTHACHE 1 0.0001
322 OSTEOMYELITIS 1 0.0001
323 C-REACTIVE PROTEIN INCREASED 2 0.0001
324 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
325 DYSURIA 2 0.0001
326 BLOOD GLUCOSE ABNORMAL 1 0.0001
327 BRONCHITIS 4 0.0001
328 CONJUNCTIVITIS 1 0.0001
329 EYE SWELLING 2 0.0001
330 URTICARIA 9 0.0001
331 NECK PAIN 3 0.0001
332 MIDDLE INSOMNIA 1 0.0001
333 HEPATIC CIRRHOSIS 1 0.0001
334 PHOTOPHOBIA 1 0.0001
335 INTESTINAL OBSTRUCTION 2 0.0001
336 BLOOD SODIUM DECREASED 1 0.0001
337 HYPOCALCAEMIA 1 0.0001
338 FRACTURE 1 0.0001
339 PULMONARY EMBOLISM 5 0.0001
340 INSOMNIA 14 0.0001
341 DEHYDRATION 7 0.0001
342 SLEEP APNOEA SYNDROME 1 0.0001
343 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
344 PRODUCT SUBSTITUTION ISSUE 3 0.0001
345 CHOLESTASIS 1 0.0001
346 HERNIA 1 0.0001
347 VISION BLURRED 7 0.0001
348 KIDNEY INFECTION 1 0.0001
349 MEMORY IMPAIRMENT 7 0.0001
350 SINUS DISORDER 1 0.0001
351 ABNORMAL BEHAVIOUR 2 0.0001
352 DISORIENTATION 2 0.0001
353 FULL BLOOD COUNT DECREASED 1 0.0000
354 PRODUCT PHYSICAL ISSUE 1 0.0000
355 PRODUCT ADMINISTRATION ERROR 1 0.0000
356 TASTE DISORDER 1 0.0000
357 PSORIATIC ARTHROPATHY 2 0.0000
358 NEUTROPHIL COUNT DECREASED 2 0.0000
359 SINUSITIS 5 0.0000
360 TOOTH LOSS 1 0.0000
361 POLLAKIURIA 2 0.0000
362 DERMATITIS 1 0.0000
363 IRRITABLE BOWEL SYNDROME 1 0.0000
364 LIVER FUNCTION TEST INCREASED 1 0.0000
365 POOR QUALITY SLEEP 1 0.0000
366 BALANCE DISORDER 4 0.0000
367 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
368 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
369 MUSCULOSKELETAL STIFFNESS 4 0.0000
370 MELAENA 1 0.0000
371 LIVER DISORDER 2 0.0000
372 TRANSAMINASES INCREASED 1 0.0000
373 GLOSSODYNIA 1 0.0000
374 THROAT IRRITATION 2 0.0000
375 PANCREATITIS ACUTE 1 0.0000
376 CHROMATURIA 1 0.0000
377 APPLICATION SITE PRURITUS 1 0.0000
378 PRODUCT AVAILABILITY ISSUE 1 0.0000
379 INJECTION SITE REACTION 3 0.0000
380 SKIN DISCOLOURATION 2 0.0000
381 MUSCLE TWITCHING 1 0.0000
382 BLOOD CHOLESTEROL INCREASED 2 0.0000
383 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
384 INJURY 3 0.0000
385 PRODUCT USE ISSUE 8 0.0000
386 PRODUCTIVE COUGH 2 0.0000
387 RASH ERYTHEMATOUS 2 0.0000
388 MOBILITY DECREASED 3 0.0000
389 BLOOD PRESSURE FLUCTUATION 1 0.0000
390 BLOOD GLUCOSE DECREASED 2 0.0000
391 CONTUSION 4 0.0000
392 FIBROMYALGIA 1 0.0000
393 PRESYNCOPE 1 0.0000
394 URINARY TRACT INFECTION 7 0.0000
395 LIVER INJURY 1 0.0000
396 DYSPEPSIA 4 0.0000
397 ABASIA 1 0.0000
398 AGEUSIA 1 0.0000
399 PNEUMONIA ASPIRATION 1 0.0000
400 FLUSHING 4 0.0000
401 HEPATITIS 1 0.0000
402 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
403 ANAPHYLACTIC SHOCK 1 0.0000
404 RASH GENERALISED 1 0.0000
405 HAEMATOMA 1 0.0000
406 RESPIRATORY TRACT INFECTION 1 0.0000
407 ABDOMINAL DISTENSION 4 0.0000
408 DEAFNESS 1 0.0000
409 GASTRITIS 1 0.0000
410 EAR INFECTION 1 0.0000
411 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
412 PAIN OF SKIN 1 0.0000
413 DISTURBANCE IN ATTENTION 2 0.0000
414 BLOOD BILIRUBIN INCREASED 1 0.0000
415 FREQUENT BOWEL MOVEMENTS 1 0.0000
416 DRY MOUTH 3 0.0000
417 ANAEMIA 7 0.0000
418 HAEMATOCHEZIA 2 0.0000
419 DIVERTICULITIS 1 0.0000
420 PROCEDURAL PAIN 1 0.0000
421 ARTHROPATHY 2 0.0000
422 HAEMOPTYSIS 1 0.0000
423 PANCYTOPENIA 2 0.0000
424 WOUND 1 0.0000
425 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
426 HYPONATRAEMIA 2 0.0000
427 ASTHMA 4 0.0000
428 PAIN IN JAW 1 0.0000
429 DEPRESSION 8 0.0000
430 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
431 ANGINA PECTORIS 1 0.0000
432 PYREXIA 12 0.0000
433 NEEDLE ISSUE 1 0.0000
434 DYSSTASIA 1 0.0000
435 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
436 CATARACT 2 0.0000
437 HYPOAESTHESIA 5 0.0000
438 HEPATIC FAILURE 1 0.0000
439 FALL 11 0.0000
440 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
441 OEDEMA PERIPHERAL 4 0.0000
442 EPILEPSY 1 0.0000
443 INJECTION SITE RASH 1 0.0000
444 PERIPHERAL SWELLING 5 0.0000
445 CHEST PAIN 6 0.0000
446 FEMUR FRACTURE 1 0.0000
447 WEIGHT DECREASED 9 0.0000
448 NERVOUS SYSTEM DISORDER 1 0.0000
449 BONE DENSITY DECREASED 1 0.0000
450 DYSPNOEA 18 0.0000
451 MIGRAINE 3 0.0000
452 CYSTITIS 1 0.0000
453 MOOD SWINGS 1 0.0000
454 MOVEMENT DISORDER 1 0.0000
455 HIP FRACTURE 1 0.0000
456 CONFUSIONAL STATE 5 0.0000
457 ATRIAL FIBRILLATION 3 0.0000
458 PAIN IN EXTREMITY 9 0.0000
459 IMPAIRED HEALING 1 0.0000
460 OSTEONECROSIS 1 0.0000
461 STAPHYLOCOCCAL INFECTION 1 0.0000
462 DECREASED APPETITE 7 0.0000
463 TREMOR 5 0.0000
464 VISUAL ACUITY REDUCED 1 0.0000
465 BLOOD PRESSURE DECREASED 2 0.0000
466 ABDOMINAL PAIN 7 0.0000
467 VIRAL INFECTION 1 0.0000
468 SYNCOPE 3 0.0000
469 URINARY RETENTION 1 0.0000
470 GAIT INABILITY 1 0.0000
471 TYPE 2 DIABETES MELLITUS 1 0.0000
472 MALAISE 13 0.0000
473 HAEMATURIA 1 0.0000
474 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
475 GASTRIC DISORDER 1 0.0000
476 DEVICE USE ERROR 1 0.0000
477 NEOPLASM PROGRESSION 1 0.0000
478 BURNING SENSATION 2 0.0000
479 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
480 PLATELET COUNT DECREASED 3 0.0000
481 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
482 PNEUMONIA 9 0.0000
483 CRYING 1 0.0000
484 UNDERDOSE 2 0.0000
485 MUSCLE SPASMS 5 0.0000
486 INJECTION SITE MASS 1 0.0000
487 INFLUENZA 3 0.0000
488 SEPSIS 3 0.0000
489 DYSARTHRIA 1 0.0000
490 DYSPNOEA EXERTIONAL 1 0.0000
491 NAUSEA 21 0.0000
492 DIARRHOEA 17 0.0000
493 HOSPITALISATION 4 0.0000
494 SEIZURE 3 0.0000
495 VOMITING 12 0.0000
496 ALOPECIA 5 0.0000
497 INJECTION SITE BRUISING 2 0.0000
498 CARDIAC FAILURE 2 0.0000
499 JOINT SWELLING 3 0.0000
500 SOMNOLENCE 5 0.0000
501 DYSKINESIA 1 0.0000
502 FATIGUE 19 0.0000
503 CARDIAC ARREST 2 0.0000
504 VISUAL IMPAIRMENT 3 0.0000
505 INJECTION SITE ERYTHEMA 3 0.0000
506 DIZZINESS 12 0.0000
507 CARDIO-RESPIRATORY ARREST 1 0.0000
508 ROAD TRAFFIC ACCIDENT 1 0.0000
509 CEREBROVASCULAR ACCIDENT 4 0.0000
510 OSTEOARTHRITIS 1 0.0000
511 HYPOACUSIS 1 0.0000
512 DEVICE DISLOCATION 1 0.0000
513 SEPTIC SHOCK 1 0.0000
514 MENTAL DISORDER 1 0.0000
515 DRUG WITHDRAWAL SYNDROME 2 0.0000
516 TACHYCARDIA 2 0.0000
517 COLITIS ULCERATIVE 1 0.0000
518 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
519 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
520 NEUTROPENIA 3 0.0000
521 SKIN IRRITATION 1 0.0000
522 NEPHROLITHIASIS 1 0.0000
523 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
524 HYPERSENSITIVITY 4 0.0000
525 COGNITIVE DISORDER 1 0.0000
526 SWELLING 2 0.0000
527 OCULAR HYPERAEMIA 1 0.0000
528 DYSPHAGIA 2 0.0000
529 DISEASE RECURRENCE 1 0.0000
530 HEADACHE 13 0.0000
531 HYPOGLYCAEMIA 1 0.0000
532 LUNG DISORDER 1 0.0000
533 PRODUCT DOSE OMISSION ISSUE 6 0.0000
534 LEUKOPENIA 1 0.0000
535 HYPOTENSION 4 0.0000
536 FLUID RETENTION 1 0.0000
537 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
538 INFLAMMATION 1 0.0000
539 HAEMORRHAGE 2 0.0000
540 PARAESTHESIA 3 0.0000
541 DEPRESSED MOOD 1 0.0000
542 DRUG INTERACTION 3 0.0000
543 HYPERTENSION 4 0.0000
544 ASTHENIA 7 0.0000
545 DRUG EFFECT DECREASED 1 0.0000
546 RASH 8 0.0000
547 PAIN 11 0.0000
548 ABDOMINAL DISCOMFORT 3 0.0000
549 COUGH 5 0.0000
550 OXYGEN SATURATION DECREASED 1 0.0000
551 MYALGIA 3 0.0000
552 RHEUMATOID ARTHRITIS 2 0.0000
553 CONVULSION 1 0.0000
554 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
555 BACK PAIN 4 0.0000
556 COVID-19 3 0.0000
557 DYSPHONIA 1 0.0000
558 PALPITATIONS 2 0.0000
559 BONE PAIN 1 0.0000
560 CHILLS 2 0.0000
561 NASAL CONGESTION 1 0.0000
562 DISEASE PROGRESSION 2 0.0000
563 ARTHRALGIA 7 0.0000
564 FEELING ABNORMAL 4 0.0000
565 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
566 STOMATITIS 1 0.0000
567 ILL-DEFINED DISORDER 1 0.0000
568 VERTIGO 1 0.0000
569 NASOPHARYNGITIS 3 0.0000
570 EXPOSURE DURING PREGNANCY 1 0.0000
571 LOSS OF CONSCIOUSNESS 2 0.0000
572 HYPERHIDROSIS 2 0.0000
573 DEEP VEIN THROMBOSIS 1 0.0000
574 BLOOD CREATININE INCREASED 1 0.0000
575 DRUG INEFFECTIVE 20 0.0000
576 FEBRILE NEUTROPENIA 1 0.0000
577 DRY SKIN 2 0.0000
578 PRODUCT QUALITY ISSUE 2 0.0000
579 HEPATIC ENZYME INCREASED 1 0.0000
580 ERYTHEMA 3 0.0000
581 ABDOMINAL PAIN UPPER 3 0.0000
582 SLEEP DISORDER 1 0.0000
583 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
584 SKIN BURNING SENSATION 1 0.0000
585 CONSTIPATION 3 0.0000
586 RESPIRATORY FAILURE 1 0.0000
587 WEIGHT INCREASED 3 0.0000
588 EPISTAXIS 1 0.0000
589 HALLUCINATION 1 0.0000
590 HOT FLUSH 1 0.0000
591 DIABETES MELLITUS 1 0.0000
592 INJECTION SITE SWELLING 1 0.0000
593 PRURITUS 5 0.0000
594 INJECTION SITE HAEMORRHAGE 1 0.0000
595 THROMBOSIS 1 0.0000
596 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
597 TREATMENT FAILURE 1 0.0000
598 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
599 RENAL IMPAIRMENT 1 0.0000
600 SKIN EXFOLIATION 1 0.0000
601 MYOCARDIAL INFARCTION 2 0.0000
602 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
603 GASTROINTESTINAL DISORDER 1 0.0000
604 DEVICE ISSUE 1 0.0000
605 ADVERSE DRUG REACTION 1 0.0000
606 ADVERSE EVENT 1 0.0000
607 OROPHARYNGEAL PAIN 1 0.0000
608 BREAST CANCER 1 0.0000
609 CARDIAC DISORDER 1 0.0000
610 BLOOD GLUCOSE INCREASED 2 0.0000
611 NEUROPATHY PERIPHERAL 1 0.0000
612 DRUG INTOLERANCE 1 0.0000
613 HEART RATE INCREASED 1 0.0000
614 CONDITION AGGRAVATED 3 0.0000
615 CHEST DISCOMFORT 1 0.0000
616 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
617 ILLNESS 1 0.0000
618 DEATH 8 0.0000
619 OVERDOSE 2 0.0000
620 OFF LABEL USE 8 0.0000
621 THROMBOCYTOPENIA 1 0.0000
622 PSORIASIS 1 0.0000
623 RENAL FAILURE 1 0.0000
624 ANXIETY 2 0.0000
625 INFECTION 1 0.0000
626 ACUTE KIDNEY INJURY 1 0.0000
627 DRUG DOSE OMISSION 1 0.0000
628 GAIT DISTURBANCE 1 0.0000
629 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
630 INCORRECT DOSE ADMINISTERED 1 0.0000
631 INJECTION SITE PAIN 1 0.0000